ストックスクリーナーアプリを入手
8.11
4.51%
0.35
アフターアワーズ：
8.12
0.010
+0.12%
前日終値:
$7.76
開ける：
$7.86
24時間の取引高:
106.20K
Relative Volume:
0.51
時価総額：
$781.10M
収益：
$106.66M
当期純損益:
$15.16M
株価収益率:
86.74
EPS:
0.0935
ネットキャッシュフロー:
$6.37M
1週間 パフォーマンス:
+4.92%
1か月 パフォーマンス:
+6.15%
6か月 パフォーマンス:
-28.17%
1年 パフォーマンス:
-34.54%
1日の値動き範囲:
$7.86
$8.40
1週間の範囲:
$7.47
$8.40
52週間の値動き範囲:
$6.11
$19.00
Gyre Therapeutics Inc Stock (GYRE) Company Profile
名前
Gyre Therapeutics Inc
セクター
電話
(619) 949-3681
住所
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
GYRE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GYRE
Gyre Therapeutics Inc
|
8.11 | 704.82M | 106.66M | 15.16M | 6.37M | 0.0935 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.08 | 99.27B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.96 | 62.28B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.18 | 59.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
707.96 | 43.34B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
300.14 | 36.72B | 3.81B | -644.79M | -669.77M | -6.24 |
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-11 | 開始されました | Noble Capital Markets | Outperform |
| 2021-04-29 | 再開されました | Stephens | Overweight |
| 2021-02-10 | 開始されました | Piper Sandler | Overweight |
| 2020-05-21 | 開始されました | Raymond James | Outperform |
| 2019-01-04 | 開始されました | Oppenheimer | Outperform |
| 2018-02-12 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2018-02-09 | 繰り返されました | Chardan Capital Markets | Buy |
| 2017-12-08 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-06-12 | 開始されました | Chardan Capital Markets | Buy |
| 2017-06-06 | 開始されました | Ladenburg Thalmann | Buy |
| 2016-06-30 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Gyre Therapeutics Inc (GYRE) 最新ニュース
Can a trend reversal in Gyre Therapeutics Inc. lead to recoveryJuly 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Gyre Therapeutics Inc. stock trendline breakdownMarket Risk Report & Safe Entry Momentum Stock Tips - Newser
Using AI based signals to follow Gyre Therapeutics Inc.2025 Market Outlook & Risk Managed Investment Strategies - Newser
How to build a custom watchlist for Gyre Therapeutics Inc.July 2025 Volume & Reliable Price Breakout Alerts - Newser
Combining price and volume data for Gyre Therapeutics Inc.Trade Analysis Summary & Safe Entry Trade Reports - Newser
How to interpret RSI for Gyre Therapeutics Inc. stockPortfolio Risk Summary & Growth Focused Entry Point Reports - Newser
Advanced analytics toolkit walkthrough for Gyre Therapeutics Inc.July 2025 Market Mood & Weekly Momentum Picks - Newser
Gyre Therapeutics Gains Attention As Under-The-Radar Liver Fibrosis Drug Maker - Benzinga
Has Gyre Therapeutics Inc. formed a bullish divergenceJuly 2025 Fed Impact & Verified Momentum Watchlists - Newser
Using portfolio simulators with Gyre Therapeutics Inc. includedProfit Target & Low Risk High Win Rate Stock Picks - Newser
H.C. Wainwright initiates Gyre Therapeutics stock with Buy rating on MASH potential - Investing.com
This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - Benzinga
How moving averages guide Gyre Therapeutics Inc. trading2025 Price Momentum & Community Driven Trade Alerts - Newser
Analyzing drawdowns of Gyre Therapeutics Inc. with statistical toolsWeekly Stock Analysis & AI Based Trade Execution Alerts - Newser
What’s the recovery path for long term holders of Gyre Therapeutics Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Technical analysis overview for Gyre Therapeutics Inc. stockTrade Volume Report & Real-Time Buy Signal Alerts - Newser
Is Gyre Therapeutics Inc. benefiting from interest rate changes2025 Trade Ideas & Long-Term Growth Plans - theviewers.co.kr
Predicting Gyre Therapeutics Inc. trend using moving averagesEarnings Performance Report & Capital Efficiency Focused Ideas - Newser
Can Gyre Therapeutics Inc. weather a recessionJuly 2025 Sentiment & Risk Controlled Daily Plans - theviewers.co.kr
Is Gyre Therapeutics Inc. meeting your algorithmic filter criteria2025 Retail Activity & Safe Capital Growth Tips - Newser
Gyre Therapeutics Inc. stock trend outlook and recovery path2025 Analyst Calls & Fast Entry High Yield Stock Tips - Newser
Gyre Therapeutics Appoints Dan Weng to Board - The Globe and Mail
Can Gyre Therapeutics Inc. sustain its profitabilityQuarterly Earnings Summary & AI Optimized Trade Strategies - theviewers.co.kr
Solid Earnings May Not Tell The Whole Story For Gyre Therapeutics (NASDAQ:GYRE) - simplywall.st
Medpace Holdings, Inc. shares rise 1.93% intraday after Dan Weng, CEO of Medelis, Inc., appointed to Gyre Therapeutics' Board. - AInvest
Gyre Therapeutics appoints Dan Weng to board of directors By Investing.com - Investing.com Australia
Gyre Therapeutics appoints Dan Weng to board of directors - Investing.com India
Gyre Therapeutics, Inc. Appoints Dan Weng to Its Board of Directors, Effective August 18, 2025 - MarketScreener
Gyre Therapeutics' Strategic Board Expansion and Pipeline Momentum: A High-Conviction Play in Fibrosis Therapeutics - AInvest
Gyre Therapeutics Announces the Appointment of Dan Weng, M.D., to Board of Directors - GlobeNewswire
40-Year Clinical Trial Expert Dan Weng Joins Gyre Therapeutics Board to Guide Global Pipeline - Stock Titan
Gyre Therapeutics Inc. At Critical Juncture — Bounce or BreakdownWeekly Investment Summary & Free Expert Verified Stock Movement Alerts - beatles.ru
Is Gyre Therapeutics Inc. a potential multi baggerWeekly Investment Recap & Long Hold Capital Preservation Plans - sundaytimes.kr
What is Gyre Therapeutics Inc. s revenue forecastJuly 2025 Pullbacks & Fast Momentum Entry Tips - sisain.net
Gyre Therapeutics shares fall 2.57% intraday due to lock-up agreement on certain common stock. - AInvest
Price momentum metrics for Gyre Therapeutics Inc. explainedPortfolio Return Summary & Safe Entry Momentum Tips - Newser
Moving Averages: Can Gyre Therapeutics Inc. be recession proofQuarterly Earnings Report & Growth Focused Investment Plans - theviewers.co.kr
Published on: 2025-08-21 08:23:58 - classian.co.kr
Gyre Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionRisk Management & Consistent Profit Trade Alerts - mustnews.co.kr
News impact scoring models applied to Gyre Therapeutics Inc.Portfolio Growth Summary & Community Supported Trade Ideas - Newser
RSI + MACD Show Convergence for Gyre Therapeutics Inc.July 2025 Outlook & Growth Oriented Trade Recommendations - Newser
Tools to assess Gyre Therapeutics Inc.’s risk profileRate Hike & Safe Entry Point Alerts - Newser
Can Gyre Therapeutics Inc. recover in the next quarterInsider Selling & High Yield Stock Recommendations - Newser
Can you recover from losses in Gyre Therapeutics Inc.Oil Prices & Capital Efficient Trading Techniques - Newser
Is Gyre Therapeutics Inc. reversing from oversold territoryTrade Volume Summary & Short-Term High Return Ideas - Newser
Gyre Therapeutics Inc (GYRE) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
8.06%
大文字化:
|
ボリューム (24 時間):